` IGPH (IGEA Pharma NV) vs Swiss Market Index Comparison - Alpha Spread

IGPH
vs
S
Swiss Market Index

Over the past 12 months, IGPH has underperformed Swiss Market Index, delivering a return of 0% compared to the Swiss Market Index's +6% growth.

Stocks Performance
IGPH vs Swiss Market Index

Loading
IGPH
Swiss Market Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
IGPH vs Swiss Market Index

Performance Gap Between IGPH and SSMI
HIDDEN
Show

Performance By Year
IGPH vs Swiss Market Index

Loading
IGPH
Swiss Market Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
IGEA Pharma NV vs Peers

Swiss Market Index
IGPH
LEG
GNL
PMT
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

IGEA Pharma NV
Glance View

Market Cap
505.5k CHF
Industry
Health Care

IGEA Pharma NV is a health-tech company focused on measure and control of test factors related to life-threatening diseases. The company is headquartered in Hoofddorp, Noord-Holland. The company went IPO on 2018-12-20. The firm focuses on research and development of biomedical solutions for the prevention of diabetes and Alzheimer's disease. Its offering portfolio includes medical testing devices and dietary supplements. The firm develops ALZ-1 Test, a blood test to measure and control level of free copper, also known as Free Copper II or Non-Ceruloplasmin Copper in the bloodstream, which is a major recognized modifiable risk factor for the Alzheimer’s disease. The firm offers its services in the Netherlands.

IGPH Intrinsic Value
Not Available
Back to Top